Vorapaxar in the Secondary Prevention of Atherothrombotic EventsDavid A. Morrow, Sabina A. Murphy, Eugene Braunwald et al.|New England Journal of Medicine|2012Cited by 941
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary SyndromesPierluigi Tricoci, Kenneth W. Mahaffey, A. Kilian et al.|New England Journal of Medicine|2011Cited by 753
Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction AnginaJohn A. Bittl, Burt Adelman, John Strony et al.|New England Journal of Medicine|1995Cited by 496
Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosisJohn Strony, Burt Adelman, A.J. Beaudoin et al.|American Journal of Physiology-Heart and Circulatory Physiology|1993Cited by 202
Aurintricarboxylic acid in a canine model of coronary artery thrombosis.John Strony, Burt Adelman, M. Phillips et al.|Circulation|1990Cited by 78